Core Viewpoint - Electrolux AB (ELUXY) is showing potential for a bullish breakout due to a recent "golden cross" in its moving averages, indicating a positive technical outlook [1]. Technical Analysis - ELUXY's 50-day simple moving average has crossed above its 200-day simple moving average, forming a "golden cross," which is a significant bullish indicator [1]. - A successful golden cross event consists of three stages: the stock price bottoms out, the shorter moving average crosses above the longer one, and the stock maintains upward momentum [2]. Performance Metrics - Over the past four weeks, ELUXY shares have increased by 10.4% [3]. - The company currently holds a 3 (Hold) rating on the Zacks Rank, suggesting potential for further gains [3]. Earnings Outlook - The earnings outlook for ELUXY is positive, with no downward revisions in earnings estimates over the past two months and two upward revisions, leading to an increase in the Zacks Consensus Estimate [3][5].

Core Viewpoint - MARKER THERAPEUTICS, INC. (MRKR) shows potential as a stock pick due to a recent "golden cross" event, indicating a bullish trend reversal [1][4]. Technical Analysis - A "golden cross" occurs when a stock's short-term moving average (50-day) crosses above its long-term moving average (200-day), signaling a bullish breakout [2]. - The formation of a golden cross involves three stages: a downtrend that bottoms out, the crossover of moving averages, and continued upward momentum [3]. Performance Metrics - MRKR has experienced a 24.8% rally over the past four weeks, suggesting strong upward momentum [4]. - The company currently holds a 1 (Strong Buy) rating on the Zacks Rank, indicating positive market sentiment [4]. Earnings Expectations - There has been one upward revision in earnings expectations for the current quarter, with no downward changes in the past 60 days, further supporting the bullish outlook [4]. - The Zacks Consensus Estimate for MRKR has also increased, reinforcing investor confidence in the stock's potential [4]. Investment Consideration - Given the technical indicators and positive earnings revisions, MRKR should be considered for inclusion on investors' watchlists [5].

Core Viewpoint - Moderna Inc has emerged as a surprising top performer in the S&P 500 for the year-to-date, with a gain of over 20% in just three trading days, indicating a potential trend reversal rather than a temporary bounce [1][2]. Technical Analysis - The stock has shown a golden cross, where the 50-day moving average has crossed above the 200-day moving average, a signal often associated with trend reversals [2]. - Currently trading around $35.66, Moderna's stock is still significantly below its 52-week high of $48.92, suggesting potential for further upward movement [3]. - Momentum indicators such as the RSI near 69 indicate strong buying interest without being overbought, while the MACD at 1.54 confirms accelerating upside momentum [3]. Short-term Trends - Short-term moving averages are positioned above longer-term ones, with the eight-day and 20-day SMAs both above $31, reinforcing the strength of the near-term trend [4]. - The timing of this movement is notable as it occurs during a period when investors are likely reshuffling portfolios, potentially favoring previously discounted stocks [5]. Market Positioning - Despite the recent surge, Moderna's stock remains closer to its 52-week low of $22.29 than its highs, a factor that technical traders often consider significant [5]. - The golden cross places Moderna on the early-2026 watchlist, suggesting that if momentum continues, this could indicate a reassertion of a longer-term trend rather than a mere short-term bounce [6].

Core Insights - The cryptocurrency market is seeing renewed interest in Bitcoin and altcoins as 2026 begins, with indications that credible altcoins may be gaining traction [1] - The CoinShares Altcoins ETF (DIME) is positioned to benefit from this altcoin momentum, following the CoinShares Compass Index which focuses on higher-tier altcoins [2] Altcoin Market Dynamics - The Altcoin Season Index is nearing 40%, with altcoin market capitalization recovering to $1.3 trillion, suggesting that major altcoins like Solana (SOL) and XRP could outperform Bitcoin [3] - Solana is highlighted as a key player in the altcoin resurgence, expected to benefit significantly from the growth of prediction markets [4] Performance Projections - Solana led all major blockchain networks by revenue in 2025 and is projected to maintain this position in 2026, driven by trends such as prediction markets [5] - The technical outlook for Cardano (ADA) is improving, with potential for DIME components to reach $2 this year, indicating substantial upside from current levels [5] Market Conditions - The emergence of a golden cross in Cardano's price charts signals positive short-term trends, with increased trading volumes and a potential breakout above key resistance levels [6] - Current market conditions resemble those preceding significant altcoin rallies in 2017 and 2021, suggesting a possible activation of a delayed cycle in the upcoming quarters [7]

Core Viewpoint - Tilly's, Inc. (TLYS) is showing potential for a bullish breakout as it has reached a significant support level and formed a "golden cross" in its moving averages [1][2]. Technical Analysis - A "golden cross" occurs when a stock's short-term moving average (50-day) crosses above its long-term moving average (200-day), indicating a bullish trend [2]. - The formation of a golden cross involves three stages: a downtrend that bottoms out, the crossover of moving averages, and subsequent upward price momentum [3]. Recent Performance - TLYS shares have increased by 27.2% over the past four weeks, indicating strong upward movement [4]. - The company currently holds a 2 (Buy) rating on the Zacks Rank, suggesting further potential for price appreciation [4]. Earnings Outlook - TLYS has a positive earnings outlook, with no earnings estimates cut and one revision higher in the past 60 days [4]. - The Zacks Consensus Estimate for TLYS has also increased, reinforcing the bullish sentiment [4][5].

Core Insights - Insurance stocks have underperformed in 2025, contrasting with previous years where home, auto, and life insurance equities showed significant alpha [1] Industry Performance - The SPDR S&P Insurance ETF has faced challenges this year, indicating a tougher market environment for insurance equities compared to prior years [1]

Core Insights - Insurance stocks have underperformed in 2025, contrasting with previous years where home, auto, and life insurance equities showed significant alpha [1] Industry Performance - The SPDR S&P Insurance ETF has faced challenges this year, indicating a tougher market environment for insurance equities compared to prior years [1]

Core Viewpoint - Mitek Systems, Inc. (MITK) is showing potential for a bullish breakout following a "golden cross" technical pattern, indicating a favorable investment opportunity [1][2]. Technical Analysis - MITK's 50-day simple moving average has crossed above its 200-day simple moving average, forming a "golden cross," which is a significant bullish indicator in trading [1][2]. - A successful golden cross event consists of three stages: the stock price bottoms out, the shorter moving average crosses above the longer moving average, and the stock maintains upward momentum [3]. Performance Metrics - Over the past four weeks, MITK has experienced an 18.6% rally, suggesting strong upward movement [4]. - Currently, MITK holds a 2 (Buy) rating on the Zacks Rank, reinforcing the potential for further gains [4]. Earnings Outlook - There have been no cuts to earnings estimates for the current quarter, with two revisions higher in the past 60 days, indicating a positive earnings outlook [4]. - The Zacks Consensus Estimate for MITK has also increased, further supporting the bullish case for the stock [4][6].

Group 1 - Midland States Bancorp, Inc. (MSBI) has reached a key level of support, indicating a potential investment opportunity from a technical perspective [1] - A "golden cross" has occurred, with MSBI's 50-day simple moving average crossing above its 200-day simple moving average, suggesting a potential bullish breakout [1] - Over the past four weeks, MSBI has gained 31.9%, and it currently holds a 3 (Hold) rating on the Zacks Rank, indicating the stock could be poised for further upward movement [3] Group 2 - The golden cross pattern consists of three stages: a downtrend that bottoms out, a crossover of the shorter moving average over the longer one, and an upward price trend [2] - There have been no downward changes in earnings expectations for MSBI over the past 60 days, with the Zacks Consensus Estimate moving up, reinforcing the bullish outlook [3] - Investors are encouraged to consider adding MSBI to their watchlist due to the significant technical indicator and positive earnings estimate trends [4]

Group 1 - X4 Pharmaceuticals, Inc. (XFOR) has reached a key level of support, indicating a potential bullish breakout as its 50-day simple moving average has crossed above its 200-day simple moving average, forming a "golden cross" [1] - A golden cross signifies a trend reversal, starting from a downtrend, followed by the shorter moving average crossing above the longer moving average, and culminating in an upward price movement [2] - XFOR shares have increased by 8.4% over the past four weeks, and the company holds a 3 (Hold) rating on the Zacks Rank, suggesting a potential for further gains [3] Group 2 - There have been four upward revisions in earnings expectations for XFOR in the current quarter, with no downward revisions, indicating a positive sentiment among investors [3] - The Zacks Consensus Estimate for XFOR has also moved up, reinforcing the bullish outlook for the company [5]